Navigation Links
2012 Forecast for US Molecular Diagnostics Market Now Available From Global Information Inc.
Date:4/16/2012

FARMINGTON, Conn., April 16, 2012 /PRNewswire-iReach/ -- Global Information Inc. is pleased to announce two significant new developments in biotechnology and biomarker market research with the release of the Venture Planning Group's annual survey of the US molecular diagnostics market, available immediately, and remaining limited registration for the Biomarker World Congress in Philadelphia in May.

The 2012 US Molecular Diagnostics Market

The Venture Planning Group has released the 2012 edition of their annual report on the state of the US molecular diagnostics market. Spanning 880 pages and including 37 tables of data, this market research report presents a comprehensive analysis of the US molecular diagnostics market, including major issues pertaining to the US molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.

Buyers will also gain access to an extensive review of DNA probe and biochip technologies, test formats, detection methodologies, and trends in testing automation and amplification methods. The report highlights ten-year test volume and reagent sales forecasts in the categories of infectious diseases, genetic diseases, cancer, paternity testing, HLA typing, and forensic testing. Also, the topics of testing methodologies and instrumentation technologies, as well as a feature comparison of automated and semiautomated analyzers and sales and market shares of leading suppliers are all compiled. In sum, over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products are discussed.

An Executive Summary of this research and a free sample of the full report are available at http://www.giiresearch.com/report/vpg224815-future-us-molecular-diagnostics-market-growth.html

8th Annual Biomarker World Congress

Professionals invested in the biomarkers market will find significant value in the Cambridge Health Institute's 8th annual Biomarker World Congress in Philadelphia, PA May 21-23, 2012. Join hundreds of biotechnology peers to network, exchange knowledge, and discuss developments with a distinguished faculty of over 40 professionals across four different tracks, Biomarkers in Drug Development, Molecular Diagnostics, Biomarker Assay Development, and Executive Summit: Drug-Diagnostic Co-Development.

Additional information is available at http://www.giiconference.com/chi214653-2012/

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com

 


'/>"/>
SOURCE Global Information Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Severe climate change costs forecast for Pennsylvania, N.C., Tennessee, N.D.
2. Global Viral Forecasting Initiative receives $11M to implement pandemic early warning system
3. Getting warmer? Prehistoric climate can help forecast future changes
4. To improve forecasting earthquakes, NJIT mathematician studies grains
5. NASA uses satellite to unearth innovation in crop forecasting
6. NOAA forecast predicts large dead zone for Gulf of Mexico this summer
7. New project to forecast toxic algal blooms on Pacific Northwest beaches
8. Evolutionary forecasting for drug resistance
9. New UC Davis study: Climate tipping points may arrive without warning, says top forecaster
10. New Report - Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014) By MarketsandMarkets
11. Fire forecast technology could help rescue teams save lives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2016)... Minn. , Nov. 22, 2016   MedNet ... supports the entire spectrum of clinical research, is pleased ... Medical LiveWire Healthcare and Life Sciences Awards ... award caps off an unprecedented year of recognition and ... trials for over 15 years. iMedNet ...
(Date:11/17/2016)... , Nov. 17, 2016 Global Market Watch: ... Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is ... analysis for Private Biobanks shows the highest Compounded Annual Growth ... region during the analysis period 2014-2020. ... CAGR of 9.95% followed by Europe ...
(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, ... developing therapeutics focused on the gut microbiome, today ... of 25,000,000 shares of its common stock and ... stock at a price to the public of ... to Synthetic Biologics from the offering, excluding the ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... , Dec. 2, 2016 Amgen (NASDAQ: ... ) today announced the submission of a Marketing Authorization Application ... a biosimilar candidate to Avastin ® (bevacizumab). The companies ... to the EMA. "The submission of ABP ... seeks to expand our oncology portfolio," said Sean E. ...
(Date:12/2/2016)... ... , ... ACEA Biosciences, Inc. announced today that it will be presenting updated ... World Conference on Lung Cancer 2016, taking place in Vienna, Austria December 3rd-8th. ... for AC0010 in patients with advanced non-small cell lung cancer harboring the EGFR T790M ...
(Date:12/2/2016)... ... December 01, 2016 , ... ... (CSS) and the popularity of US Single Day Events (SDE) to organize a ... Summer 2018, in Raleigh, NC. Topics of the pharmaceutical and life sciences industry ...
(Date:12/2/2016)... IL (PRWEB) , ... December 01, 2016 , ... ... to congratulate long-term client Nanowear on their recent FDA Class II 510(k) clearance ... cleared a significant hurdle in commercializing remote cardiac monitoring devices that rely on ...
Breaking Biology Technology: